enen

News

Atrium sets sights on another acquisition

News - Atrium Innovations Inc., an international manufacturer and distributor of science-based dietary supplements, is planning an acquisition in the $100-million range after completing its current vertical integration program, CEO Pierre Fitzgibbon said Tuesday.

Desjardins Group wins the prestigious Structured Products House of the Year Canada Award for its quality market-linked GICs

News - Desjardins Group has been recognized for its manufacturing capabilities once again, receiving the esteemed Structured Products House of the Year Canada Award during a ceremony in Coral Gables, Florida on May 2. The prize was awarded by the internationally renowned London-based magazine Structured Products and recognized Desjardins’ innovation in the manufacturing of structured products in 2012.

Atrium Innovations Extends Research Partnership with Institute of Nutrition and Functional Foods (INAF)

News - Atrium Innovations announces that it has extended its research partnership with the Institute of Nutrition and Functional Foods ("INAF"). In June 2011, Atrium launched a comprehensive applied clinical research program in collaboration with INAF at Université Laval in Quebec City. The original program was funded through the end of 2013.

InnovMetric and Thai Business Partner Launch PolyWorks Thailand

News - Following three years of successful cooperation, InnovMetric Software Inc. and its Thai business partner, Mr. Chaiyasit Thongplio of PW Technical Support (Thailand) Co. Ltd., proudly announced today the launch of PolyWorks Thailand.

DEQ wins best table gaming technology award for real link at the 2013 Inside Asian Gaming Supplier Awards

News - DEQ Systems Corp., a leading provider of table game bonusing, progressive jackpot and table game linking solutions, is proud to announce today that its wide area table game progressive management system, Real Link™, has won in the Best Table Gaming Technology category in the 2013 edition of the Inside Asian Gaming Supplier Awards.

Quebec home retrofitted to reduce the impact of winter storms and earthquakes

News - The Institute for Catastrophic Loss Reduction (ICLR) in partnership with Desjardins retrofitted a Quebec home to reduce the impact of winter storms and earthquakes. As part of the insurance industry’s ongoing commitment to educate Canadian homeowners about disaster safety, ICLR has once again chosen Emergency Preparedness Week (May 5-11) to unveil its latest home retrofit project, this time in Quebec City, Quebec.

Medicago successfully produces VLP vaccine candidate for H7N9 virus responsible for recent influenza outbreak in China

News - Medicago announced that it has successfully produced a new VLP vaccine candidate for the H7N9 virus that is responsible for the current influenza outbreak in China. "To our knowledge, Medicago is the first to produce a VLP vaccine candidate against this potential pandemic strain demonstrating our ability to be a first responder in a pandemic scenario," said Andy Sheldon, President and CEO of Medicago.

$20m to fund cyber strategies

News - Stating that “sophisticated threats demand sophisticated responses,” Defence Minister Peter MacKay has committed $20 million to fund projects aimed at making Canada safer from cyber attacks. Among the 26 science and technology initiatives to receive funding is a joint government-academic project to develop capabilities to “identify, locate and mitigate potential wireless security threats,” strengthen Canada's digital infrastructure, and improve responses to cyber threats. The partners in the project are Defence Research and Development Canada, Laval University in Quebec City and the University of Western Ontario in London.

Fostering collaboration to address real-world problems in the area of cognition

News - The Cognition Challenge welcomes applications from Canadian Entrepreneurs to address the significant unmet medical needs related to Alzheimer's disease and cognitive disorders. The Cognition Challenge is looking for Canadian researchers and entrepreneurs who are using leading edge science and innovative approaches to address questions related to learning and memory (see below) and to collaborate with them to advance their work to the next level.

AmorChem and InflammatoRx to collaborate on the development of drugs to treat inflammatory and auto-immune diseases

News - AmorChem and InflammatoRx are proud to announce the launch of a research collaboration on inflammatory and auto-immune diseases. The collaboration targets S100A9, a protein playing a key role in inflammation as demonstrated by Dr. Philippe Tessier (Professor, Department of Microbiology, Infectiology and Immunology at the Faculty of Medicine of Université Laval). InflammatoRx, a biotechnology company, was started up in 2009 around the work of Dr. Tessier.

Newsletter

Subscribe to our newsletter for interesting news and information.

Print this page